EP-1612: Pre-treatment mpMRI accuracy and prognostic value in intermediate risk localized prostate cancer. (April 2018) - Büchser, D.; Gómez-Iturriaga, A.; Casquero, F.; Urresola, A.; Ezquerro, A.; Cacicedo, J.; San Miguel, I.; Suarez, F.; Bilbao, P.